Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Inventory Average (2016 - 2025)

Historic Inventory Average for Mimedx (MDXG) over the last 15 years, with Q3 2025 value amounting to $25.7 million.

  • Mimedx's Inventory Average rose 423.28% to $25.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.7 million, marking a year-over-year increase of 423.28%. This contributed to the annual value of $22.4 million for FY2024, which is 3106.07% up from last year.
  • As of Q3 2025, Mimedx's Inventory Average stood at $25.7 million, which was up 423.28% from $24.5 million recorded in Q2 2025.
  • Mimedx's 5-year Inventory Average high stood at $25.7 million for Q3 2025, and its period low was $10.7 million during Q3 2021.
  • Over the past 5 years, Mimedx's median Inventory Average value was $15.7 million (recorded in 2023), while the average stood at $17.6 million.
  • Its Inventory Average has fluctuated over the past 5 years, first tumbled by 118.12% in 2021, then soared by 6334.41% in 2024.
  • Over the past 5 years, Mimedx's Inventory Average (Quarter) stood at $11.3 million in 2021, then increased by 20.25% to $13.6 million in 2022, then surged by 47.61% to $20.0 million in 2023, then grew by 19.87% to $24.0 million in 2024, then rose by 6.94% to $25.7 million in 2025.
  • Its Inventory Average stands at $25.7 million for Q3 2025, versus $24.5 million for Q2 2025 and $23.9 million for Q1 2025.